AssayQuant Technologies, Inc. — Form D/A
AssayQuant Technologies, Inc. of Marlborough, MA, a company, filed a Form D amendment with the SEC on 2023-07-25. The offering totals $12.0M, of which $5.1M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2023-07-25
- Form: D/A
- Accession: 0001861955-23-000002
- Industry: Biotechnology
- Exemptions: 06c
- Total offering: $12.0M
- Amount sold: $5.1M
- Remaining: $6.9M
- Investors: 21
- Date of first sale: 2023-07-07
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-486342
Issuer
- Name: AssayQuant Technologies, Inc.
- CIK: 0001861955
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 260 CEDAR HILL STREET, Marlborough, MA, 01752
- Phone: 5088043155
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Charles Baltic | Director | Marlborough, MA |
| Jeffrey Hoerle | Director | Marlborough, MA |
| Barbara Imperiali | Director | Marlborough, MA |
| Gil Price | Director | Marlborough, MA |
| Erik Schaefer | Executive Officer | Marlborough, MA |
Other filings by this issuer (2)
More